Please login to the form below

Not currently logged in
Email:
Password:

Ex-Pfizer staff create new UK firm

Former Pfizer employees have created a research networking firm to be based in Kent, England, at a site the pharmaceutical company had previously announced it was to vacate

Former Pfizer employees have created a research networking firm to be based in Kent, England, at a site the pharmaceutical company had previously announced it was to vacate with the loss of 2,400 jobs.

Seven former Pfizer staff members will be part of The Research Network, described by its CEO, Andrew McElroy, as "a bit like a dating agency for scientists".

The firm will operate from Discovery Park in Sandwich, a site that the UK government recently announced would become an enterprise zone following Pfizer's decision to close its R&D facilities.

Pfizer put the site up for sale in June 2011, with a phased out exit to be completed by 2012.

McElroy explained that the firm would help biotech and pharmaceutical companies find the right partners for outsourcing research productivity.

He continued: "We are a talented team of experienced drug discovery scientists who have a broad knowledge of the scientific services market place, what things cost, how long projects will take and who provides the best service."

1st September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics